Why Is Andreas Halvorsen Bullish On Edgewise Therapeutics, Inc. (EWTX) Now?
We recently compiled a list of the Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against Andreas Halvorsen’s other long-term stock picks.
Stifel Initiates Coverage of Edgewise Therapeutics (EWTX) with Hold Recommendation
Fintel reports that on January 22, 2025, Stifel initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with a Hold recommendation. Analyst Price Forecast Suggests 84.07% Upside As of December 23,
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile. Read more here.
Cautious Hold Rating for Edgewise Therapeutics Amid Uncertain Differentiation and Efficacy
Paul Matteis, an analyst from Stifel Nicolaus, has initiated a new Hold rating on Edgewise Therapeutics (EWTX).Invest with Confidence: Follow
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Up 8.9% in December
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 6,
Stifel initiates Edgewise Therapeutics stock with Hold rating, $30 target
Stifel analysts began coverage of Edgewise Therapeutics (NASDAQ:EWTX), currently valued at $2.6 billion, with a Hold rating and set a price target of $30.00. According to InvestingPro data, the stock trades at $27.
Edgewise Therapeutics initiated with a Hold at Stifel
Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very
Edgewise Therapeutics promotes Behrad Derakhshan to COO
Edgewise Therapeutics (EWTX) announced changes to its executive team. These changes include the addition of Robert Blaustein, joining the ...
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced key changes ...
news.stocktradersdaily8d
How to Take Advantage of moves in (EWTX)
Check the time stamp on this data. Updated AI-Generated Signals for Edgewise Therapeutics Inc. (EWTX) available here: EWTX.
Nasdaq8d
December 19th Options Now Available For Edgewise Therapeutics (EWTX)
Investors in Edgewise Therapeutics Inc (Symbol: EWTX) saw new options become available today, for the December 19th expiration. One of the key inputs that goes into the price an option buyer is ...
Morningstar6d
Edgewise Therapeutics Inc EWTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Yahoo Finance4d
Edgewise Therapeutics, Inc. (EWTX) stock forecast and price target
Find the latest Edgewise Therapeutics, Inc. EWTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.